Therefore, in our previous studies, we also compared the serum levels of MMP-2 and TIMP-2 in patients with CRC with their expression in cancer cells, inflammatory infiltrate cells and colorectal cells from adjacent normal tissue. This evidence concerns the gene TIMP2 and colorectal carcinoma.